Finweek English Edition - - IN BRIEF -

French phar­ma­ceu­ti­cal gi­ant Sanofi will pay at least $1.7bn (R21.4bn) to en­ter a new col­lab­o­ra­tion with biotech­nol­ogy firm Re­gen­eron Phar­ma­ceu­ti­cals to de­velop drugs that har­ness the body’s im­mune sys­tem to fight can­cer, ny­times. com re­ported. The two groups re­ceived reg­u­la­tory ap­proval on 24 July for their first jointly de­vel­oped prod­uct, Pralu­ent, a drug that low­ers choles­terol, ny­times.com said.

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.